Customization of Medical-Grade Plastic Parts: Material Selection and Biocompatibility Requirements
Customization of Medical-Grade Plastic Parts: Material Selection and Biocompatibility Requirements Medical plastic parts are widely used in detection instruments, diagnostic equipment and disposable medical supplies. Different from ordinary plastic products, they need to satisfy strict biocompatibility standards, low extractable substances and stable mechanical performance. Mold design, material selection and production environment must be planned together to meet medical regulatory requirements.
Material selection for medical plastic components
Common medical materials include PC, PP, PEEK, COC and medical grade ABS. Each material has unique advantages for different usage scenarios. PP is suitable for disposable parts because of good chemical resistance and low cost. PEEK features high temperature resistance and excellent mechanical strength, which is used for reusable surgical components. COC has low birefringence and high transparency, ideal for optical detection structures. All raw materials must come from certified medical grades, with complete material traceability reports. Recycled materials are restricted in most medical applications unless they pass additional biological testing. Colorants and additives must be medical approved, to avoid harmful substances migrating to human tissue or test samples.

Biocompatibility testing standards and evaluation items
ISO 10993 is the mainstream biocompatibility standard for medical plastic products. Test items are selected according to contact duration and contact way with human body. Short-term contact parts need cytotoxicity, skin irritation and sensitization tests. Long-term implant components require additional systemic toxicity, genotoxicity and implantation tests. Even if the raw material passes biocompatibility certification, finished molded parts may fail the test because of mold release agent, residual lubricant or contamination during production. Mold cleaning and production environment control are indispensable to avoid introducing pollutants.
Mold design and precision control requirements
Medical parts usually have tight dimensional tolerance and high surface finish. Mold steel such as S136 or STAVAX is commonly used for its corrosion resistance and easy polishing. Cavity surface needs high cleanliness, and no residual rust or dirt can remain. The gating system should reduce weld lines and shear heat, because high shear may cause material degradation and increase precipitates. Cooling channels are arranged evenly to control internal stress. Excessive internal stress may lead to cracking during sterilization. The mold structure should be easy to disassemble and clean, without dead corners where residue accumulates.

Clean production and process management
Medical plastic parts are usually produced in clean workshops. Dust, hair and other particles will cause surface defects and contamination. Raw material drying, barrel cleaning and material change procedures need standardized operation. The use of external mold release agent is limited, self-lubricating medical materials are preferred. Each batch of products needs batch records, including raw material batch number, molding parameters, production date and sterilization records. The whole production chain can be traced for audit.
Sterilization adaptability verification
Medical products need sterilization such as ethylene oxide, gamma ray or high-temperature steam. Materials must keep stable performance after repeated sterilization. Some plastics will turn yellow, become brittle or lose strength after gamma radiation. Molded samples should complete sterilization simulation test before mass production. Structure design also needs to consider sterilization gas circulation, avoid enclosed cavities that are hard to fully sterilize. Biocompatibility is not only determined by raw materials. Mold design, molding process, workshop cleanliness and post-treatment together decide whether the medical plastic parts can pass compliance assessment. Full process risk assessment should be carried out in the early customization stage to avoid large-scale rework after testing failure.
